Skip to Main Content (Press Enter)

Logo UNICATT
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Persone
  • Pubblicazioni
  • Attività
  • Competenze

UNI-FIND
Logo UNICATT

|

UNI-FIND

unicatt.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Persone
  • Pubblicazioni
  • Attività
  • Competenze
  1. Pubblicazioni

Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results

Articolo
Data di Pubblicazione:
2024
Citazione:
Chiariello, G. A., Di Mauro, M., Villa, E., Koulouroudias, M., Bruno, P., Mazza, A., Pasquini, A., D'Avino, S., De Angelis, G., Corigliano, K., Marcolini, A., Zancanaro, E., Saitto, G., Meani, P., Massetti, M., Lorusso, R., Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results, <>, 2024; 13 (22): N/A-N/A. [doi:10.3390/jcm13226829] [https://hdl.handle.net/10807/303005]
Abstract:
Background: In recent years, in case of aortic valve replacement (AVR), a significant increase in the use of bioprostheses has been observed. The Perceval sutureless bioprosthesis has proven to be safe and reliable in the short and mid-term, with limited but promising long-term results. An updated systematic review with the long-term results of patients who underwent a sutureless bioprosthesis implantation with a Perceval biological valve is herewith presented. Methods: Studies published between 2015 and 2024, including the long-term outcomes—with clinical as well as echocardiographic information for up to five years—of patients who underwent a Perceval implantation for AVR were selected from the published literature. The Cochrane GRADE system was used to assess the study quality, and the risk of bias in non-randomized studies (ROBINS-I) tool was used to evaluate studies. Results: Ten studies were selected with an overall number of 5221 patients. The long-term survival ranged from 64.8 to 87.9%, freedom from structural valve degeneration (SVD) from 96.1 to 100%, freedom from significant paravalvular leak from 98.5 to 100%, freedom from prosthetic endocarditis from 90.7 to 99%, and freedom from reintervention from 94 to 100%. The long-term mortality ranged from 6.5 to 27.4%. SVD was observed in 0–4.8% patients. Significant paravalvular leak was observed in 0–3.4% patients, and infective endocarditis was observed in 0–3.4%. A bioprosthesis-related reintervention at long-term follow-up was required for 0–4.3% of patients, and 1.7–7.1% of patients required a late new pacemaker implantation. The transprosthetic mean pressure gradient ranged from 9 to 14.7 mmHg, peak pressure gradient ranged from 17.8 to 26.5 mmHg, and EOA ranged from 1.5 to 1.7 cm2. Conclusions: This systematic review shows that there is still a paucity of data about sutureless bioprostheses. Nevertheless, the clinical results from prospective studies or retrospective series are encouraging. Medium- and long-term results seem to support the increasing use of this type of prosthesis.
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
aortic valve; bioprosthetic valve; long-term outcomes; sutureless
Elenco autori:
Chiariello, Giovanni Alfonso; Di Mauro, Michele; Villa, Emmanuel; Koulouroudias, Marinos; Bruno, Piergiorgio; Mazza, Andrea; Pasquini, Annalisa; D'Avino, Serena; De Angelis, Gaia; Corigliano, Kiara; Marcolini, Alberta; Zancanaro, Edoardo; Saitto, Guglielmo; Meani, Paolo; Massetti, Massimo; Lorusso, Roberto
Link alla scheda completa:
https://publicatt.unicatt.it/handle/10807/303005
Link al Full Text:
https://publicatt.unicatt.it//retrieve/handle/10807/303005/707142/jcm-13-06829-v2.pdf
Pubblicato in:
JOURNAL OF CLINICAL MEDICINE
Journal
  • Aree Di Ricerca

Aree Di Ricerca

Settori (2)


LS4_10 - The cardiovascular system and cardiovascular diseases - (2024)

Settore MEDS-13/C - Chirurgia cardiaca
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.4.5.0